PFIZER REPORTS SECOND-QUARTER 2018 RESULTS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Oil drops more than $2 despite new US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wattmore and Eos Energy strike non-exclusive storage software deal
- Grand Canyon Education places CFO on leave amid stock trade probe
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Funds sell $44bn in semiconductors on AI concerns
- RUM Group signs $13.7 billion GPU services deal, issues warrants
Pfizer (PFE) Tops Q2 EPS by 7c, Updates Guidance
July 31, 2018 6:46 AM EDTPfizer (NYSE: PFE) reported Q2 EPS of $0.81, $0.07 better than the analyst estimate of $0.74. Revenue for the quarter came in at $13.47 billion versus the consensus estimate of $13.31 billion.
GUIDANCE:
Pfizer sees FY2018 EPS of $2.95-$3.05, versus the consensus of $2.95. Pfizer sees... More
